Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1730-1735

  Singh, Surendra P ^a   Lipman, Jennifer ^a   Goldman, Harvey ^a   Ellis Jr , F Henry ^a   Aizenman, Laura ^a   Cangi, M Giulia ^a   Signoretti, Sabina ^a   Chiaur, Dah S ^b   Pagano, Michele ^b   Loda, Massimo ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P27;

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CELLULAR DISTRIBUTION; ESOPHAGUS CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS EPITHELIUM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BLOTTING, WESTERN; CARCINOMA IN SITU; CELL CYCLE PROTEINS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYTOPLASM; ENZYME INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, MESSENGER; SUBCELLULAR FRACTIONS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 0032522414     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Spechler, S. J. Barrett's esophagus. Semin. Oncol., 21: 432-437, 1994.
2. Haggitt, R. C. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol., 25: 982-993, 1994.
3. Reid, B. J., Haggitt, R. C., Rubin, C. E., Roth, G., Surawicz, C. N., Van Belle, G., Lewin, K., Weinstein, W. M., Antonoli, D. A., Goldman, H., MacDonald, W., and Owen, D. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum. Pathol., 19: 166-178, 1988.
4. Streitz, J. M., Jr., Williamson, W. A., and Ellis, F. H., Jr. Current concepts concerning the nature and treatment of Barrett's esophagus and its complications. Ann. Thorac. Surg., 54: 586-591, 1992.
5. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
6. DelSal, G., Loda, M., and Pagano, M. Cell cycle and cancer: critical events at the G1 restriction point. Crit. Rev. Oncog., 7: 127-142, 1996.
7. Cordon-Cardo, C. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am. J. Pathol., 147: 545-560, 1995.
8. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
9. Elledge, S. J., Winston, J., and Harper, J. W. A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol., 6: 388-393, 1996.
10. Loda, M., Cukor, B., Tam, S., Lavin, P., Fiorentino, M., Draetta, G., Jessup, J., and Pagano, M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med., 3: 231-234, 1997.
11. Catzavelos, C., Bhattacharya, N., Ung, Y., Wilson, J., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., Franssen, E., Pritchard, K., and Slingerland, J. Decreased levels of the cell-cycle inhibitor p27kip1 protein: prognostic implications in primary breast cancer. Nat. Med., 3: 227-230, 1997.
12. Tan, P., Cady, B., Wanner, M., Worland, P., Cukor, B., Fiorentino, M., MagiGalluzzi, C., Lavin, P., Pagano, M., and Loda, M. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1, b) invasive breast carcinomas. Cancer Res., 57: 1259-1263, 1997.
13. Porter, P., Malone, K., Haegerty, G., Alexander, G., Gatti, L., Firpo, E., Daling, J., and Roberts, J. Expression of cell-cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med., 3: 222-225, 1997.
14. Esposito, V., Baldi, A., De Luca, A., Groger, A. M., Loda, M., Giordano, G. G., Caputi, M., Baldi, F., Pagano, M., and Giordano, A. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small-lung cancer. Cancer Res., 57: 3381-3385, 1997.
15. Mori, M., Mimori, K., Shiraishi, T., Tanaka, S., Ueo, H., Sugimachi, K., and Akiyoshi, T. p27 expression and gastric carcinoma. Nat. Med., 3: 593, 1997.
16. Yang, R. M., Naitoh, J. Murphy, M. J., Wang H-J., Philipson, J., deKernion, J. B., Loda, M., and Reiter, R. E. Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J. Urol., 159: 941-945, 1988.
17. Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res., 58: 542-548, 1998.
18. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res., 55: 1211-1214, 1995.
19. Spirin, K. S., Simpson, J. F., Tacheuchi, S., Kawamata, N., Miller, C. W., and Koeffler, H. P. p27/Kip1 mutation found in breast cancer. Cancer Res., 56: 2400-2404, 1996.
20. kip1 in human malignancies. Cancer Res., 55: 2266-2269, 1995.
21. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res., 55: 1206-1210, 1995.
22. Pagano, M., Tam, S. W., Theodoras, A. M., Romero-Beer, P., Del Sal, G., Chau, V., Yew, R., Draetta, G., and Rolfe, M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Washington DC), 269: 682-685, 1995.
23. Beahrs, O. H., Henson, D. E., Hutter, R. V. P., and Kennedy, B. J. Digestive system-esophagus. In: American Joint Committee on Cancer, pp. 57-61. Philadelphia: J. B. Lippincott Co., 1992.
24. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
25. Tarone, R., and Ware, J. On distribution-free test for equality of survival distributions. Biometrika, 64: 156-160, 1977.
26. Kip1 display increased body size, multiple organ hyperplasia, retina dysplasia, and pituitary tumors. Cell, 85: 707-721, 1996.
27. Kip1-deficient mice. Cell, 85: 733-744, 1996.
28. Kip1. Cell, 85: 721-732, 1996.
29. Blot, W. J., Devesa, S. S., Kneller, R. W., and Frumeni, J. F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J. Am. Med. Assoc., 265: 1287-1289, 1991.
30. Kip1 expression in endocrine and other tumors. Am. J. Pathol., 150: 401-407, 1997.
31. Kip1 expression is inversely proportional to the proliferative index. Am. J. Pathol., 151: 151-160, 1997.